Teva Pharmaceutical Industries Limited (TEVA) – Portfolio improvement must for growth

Teva is  a global pharmaceutical company, committed to helping patients around the world to access affordable medicines and benefit from innovations to improve their health. Its mission is to be a global leader in generics, specialty medicines and biopharmaceuticals, improving the lives of patients.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

Crispidea Coverage

No of Pages : 30